Abstract: This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.

Abstract: Aspects of the present invention provide a display support arm assembly that includes a proximal housing supporting at least one proximal shaft, a distal housing spaced from the proximal housing and supporting at least one distal shaft, and at least one link extending from the at least one proximal shaft to the at least one distal shaft. The at least one link is coupled for pivotal movement about an axis of the at least one proximal shaft. The display support assembly also includes a gas strut extending between the proximal housing and the distal housing. The gas strut provides substantially constant force throughout a range of the vertical adjustment of the display support arm. The display support assembly further includes at least one torque element associated with either or both of the at least one proximal shaft and the at least one distal shaft.

Abstract: An air filtration system for a passenger compartment of a motor vehicle includes a filter bed positioned downstream from a blower motor and upstream from one or more vents. The air filtration system additionally includes a heater coupled to the filter bed, a sensor configured to measure a functional capacity of the filter bed, and a controller configured to regenerate the filter bed using the heater as initiated by the real-time sensor.

Abstract: A method, computer program product, and computer system for managing and tracking commands associated with a change on a managed computer system. The managed computer system receives a log-on of an administrator onto the managed computer system, determines the lockdown level of the managed computer system by querying a managing computer system, and retrieves a list of authorized commands under the lockdown level from the managing computer system. The managed computer system determines, by querying the managing computer system, whether an authorized change on the managed computer system exists. The managed computer system removes the lockdown level to receive from the managing computer system authorization of commands that have been locked down, in response to determining that the authorized change exists. The managed computer system sets the lockdown level with the authorized commands on the managed computer system, in response to determining that the authorized change does not exist.

Abstract: Methods for analyzing, selecting, characterizing or classifying compositions of a co-polymer, e.g., glatiramer acetate are described. The methods entail analysis of pyro-glutamate in the composition, and, in some methods, comparing the amount of pyro-glutamate present in a composition to a reference standard.

Abstract: Systems and methods are disclosed for generating hyperspectral images, which may correspond to a three dimensional image in which two dimensions correspond to a spatial field of view and a third dimension corresponds to a frequency domain absorption spectrum. Disclosed systems and methods include those employing dual optical frequency comb Fourier transform spectroscopy and computational imaging for generation of hyperspectral images. Such a combination advantageously allows for imaging systems to exhibit low size, weight, and power, enabling small or handheld sized imaging devices.

Abstract: This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.

Abstract: Disclosed herein are novel antioxidant inflammation modulators, including those of the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds. Methods and intermediates useful for making the compounds, and methods of using the compounds and compositions thereof are also provided.

Abstract: This invention provides novel compounds comprising the following anti-inflammatory pharmacore: wherein X, R1 and R2 are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.